1,411 results on '"Atzeni, Fabiola"'
Search Results
2. Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort
3. Helicobacter pylori Infection and Gastric Autoimmunity
4. Contributors
5. Cardiovascular disease risk in systemic lupus erythematous: Certainties and controversies
6. Does the Impact of COVID‐19 on Patients With Systemic Sclerosis Change Over Time?
7. Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study
8. Microorganisms in Pathogenesis and Management of Behçet Disease (BD)
9. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort
10. C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis
11. Impact of smoking habit on adult-onset Still’s disease prognosis, findings from a multicentre observational study
12. Evidence for a genetic contribution to the ossification of spinal ligaments in Ossification of Posterior Longitudinal Ligament and Diffuse idiopathic skeletal hyperostosis: A narrative review.
13. The Functional Syndromes as Fibromyalgia Comorbidities
14. Interstitial lung disease and rheumatoid arthritis
15. Pain in Women: A Perspective Review on a Relevant Clinical Issue that Deserves Prioritization
16. Comparison of Efficacy of Ketoprofen and Ibuprofen in Treating Pain in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
17. Cardiovascular effects of approved drugs for rheumatoid arthritis
18. Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group
19. Does the impact of COVID-19 on patients with systemic sclerosis change over time?
20. Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis.
21. Correction to: Impact of smoking habit on adult-onset Still’s disease prognosis, findings from a multicentre observational study
22. Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)
23. Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study
24. Exposure to air pollution as an environmental determinant of how Sjögren's disease is expressed at diagnosis
25. Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort
26. Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry
27. Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment
28. Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks
29. Prescribing motivations and patients’ characteristics related to the use of biologic drugs in adult-onset Still’s disease: analysis of a multicentre “real-life” cohort
30. La sindrome fibromialgica: dalla diagnosi alla terapia
31. Retrotransposons shuttling genetic and epigenetic information from the nuclear to the mitochondrial compartment: Do they play a pathogenetic role in scleroderma?
32. Incidence du cancer chez les patients atteints de spondyloarthrite traités par anti-TNF
33. Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registry.
34. Influence of exposure to climate-related hazards in the phenotypic expression of primary Sjögren's syndrome
35. The use of JAK inhibitors and the impact of comorbidities
36. Does the impact of COVID‐19 on patients with systemic sclerosis change over time?
37. Bone and joint bacterial infections in patients with rheumatoid arthritis
38. Incidence of cancer in patients with spondyloarthritis treated with anti-TNF drugs
39. Prise en charge de l’infection par le virus de l’hépatite B chez les patients atteints de polyarthrite rhumatoïde : conférence de consensus italienne
40. Features of mood associated with high body weight in females with fibromyalgia
41. A Review of Chronic Musculoskeletal Pain: Central and Peripheral Effects of Diclofenac
42. Diffuse Idiopathic Skeletal Hyperostosis (DISH) and a Possible Inflammatory Component
43. Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort
44. Metabolic Syndrome and Its Components Have a Different Presentation and Impact as Cardiovascular Risk Factors in Psoriatic and Rheumatoid Arthritis
45. The Role of Alarmins in Osteoarthritis Pathogenesis: HMGB1, S100B and IL-33
46. Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study
47. Fibromyalgia: one year in review 2023
48. JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications
49. C-reactive protein level association with future cardiovascular events assessed by different risk scores among rheumatoid arthritis patients
50. Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.